Document is current
Any future updates will be listed below
-
Authors
Vitale, Fulvia https://orcid.org/0009-0000-2595-6939
Scerra, Gianluca
Marrone, Laura
Di Micco, Anna
Cannata Serio, Magda https://orcid.org/0000-0002-2084-3406
Intasiri, Amarawan
Amodio, Giuseppina
Cirillo, Vittorio
Remondelli, Paolo https://orcid.org/0000-0002-3698-3497
Luongo, Antonietta
Bonavita, Raffaella
Caporaso, Maria Gabriella
Perez, Franck https://orcid.org/0000-0002-9129-9401
Renna, Maurizio
Bell, Thomas W.
Romano, Simona https://orcid.org/0000-0002-9401-5814
D’Agostino, Massimo https://orcid.org/0000-0002-6024-0626
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 17 July 2025
First Online: 6 August 2025
Competing interests
: Massimo D’Agostino has an Italian (102024000006772) and European (EP25166272.2) patent pending applications on the luciferase reporter and the RELITE assay for screening Sec61 inhibitors. T.W. Bell and T. Kapri have a U.S. Provisional Application (63/790,874) for PD-L1 down-modulators. The authors declare no additional competing interests.
